tm logo
ZELTIGNA
WITHDRAWN

on 31 Dec 1969

Last Applicant/ Owned by

BIOXCEL THERAPEUTICS INC.

555 Long Wharf Drive, 12th FloorNew Haven CT 06516

US

Serial Number

2180705 filed on 09th Mar 2022

Correspondent Address

1100-150 York StreetToronto

ONTARIO

CA

M5H3S5

ZELTIGNA

Trademark usage description

pharmaceuticals for the treatment of central nervous system disorders; pharmaceuticals for the treatment of neurological and psychiatric disorders; ph Read More

Classification Information


Class [005]
Pharmaceuticals for the treatment of central nervous system disorders; pharmaceuticals for the treatment of neurological and psychiatric disorders; pharmaceuticals for the treatment of agitation; pharmaceuticals for the treatment of agitation associated with neuropsychiatric conditions, neurodegenerative diseases, schizophrenia, bipolar disorder, dementia, delirium, alcohol withdrawal, opioid use disorder, opioid withdrawal, substance abuse withdrawal, depression or any other central nervous system disorder; pharmaceuticals for the treatment of symptoms associated with alcohol withdrawal, opioid use disorder, opioid withdrawal, substance abuse withdrawal, depression or other central nervous system disorders.


Classification kind code

11

Mark Details


Serial Number

2180705

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 08th Aug 2023
Search Recorded
Submitted for opposition 20
on 08th Aug 2023
Examiner's First Report
Submitted for opposition 256
on 21st Feb 2023
Notification of Possible Opposition Sent
Submitted for opposition 67
on 07th Oct 2022
Agent Name Changed
Submitted for opposition 48
on 14th Jul 2022
Agent Changed
Submitted for opposition 257
on 21st Apr 2022
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 21st Apr 2022
Created
Submitted for opposition 31
on 21st Apr 2022
Formalized
Submitted for opposition 30
on 09th Mar 2022
Filed
Submitted for opposition 228
on 09th Mar 2022
International Registration